UnknownPhase 2NCT00354276
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
Studying Acute basophilic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vion Pharmaceuticals
- Principal Investigator
- Bonny L. Johnson, RN, MSNVion Pharmaceuticals
- Intervention
- cytarabine(drug)
- Enrollment
- 85 enrolled
- Eligibility
- 60 years · All sexes
- Timeline
- 2006
Study locations (3)
- Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
- Hopital Haut Leveque, Pessac, France
- University Hospital of Wales, Cardiff, Wales, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00354276 on ClinicalTrials.govOther trials for Acute basophilic leukemia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT01627041Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNCT00898456Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaAlliance for Clinical Trials in Oncology